BBH

VanEck Vectors Biotech ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

159.03
+1.49
+0.95%
Closed 16:00 10/22 EDT
OPEN
156.96
PREV CLOSE
157.54
HIGH
159.40
LOW
156.96
VOLUME
16.32K
TURNOVER
--
52 WEEK HIGH
178.10
52 WEEK LOW
112.03
TOTAL ASSET
489.50M
YTD YIELD
11.55%
1D
5D
1M
3M
1Y
5Y
News
Performance
Biotech Investing In A Time Of The Coronavirus
A broad and diverse effort is underway by biotech companies to solve the terrible riddle of the Coronavirus.Firms are forging ahead with testing, treatment and vaccine research and product development.Results of even the most promising treatments, however, are not yet clear cut. Even those that may be are not proof a bullish thesis for those companies that have developed them.Biotech investing is risky. The temptations of building a large position in a COVID 19-engaged public company are obvious.A wise investor would be well-served by opening or adding to such positions with a measure of caution.
Seekingalpha · 10/09 16:49
Is Gold’s Rally Over? Here Are Five Key Charts to Watch
Gold’s slump this week is forcing investors to ask whether the haven asset is taking a breather or facing an even sharper decline.
Bloomberg · 09/23 16:31
How One Fossil Fuel Free ETF Proved Oil Doesn’t Pay
Five years ago, State Street started a new, green fund. The world hasn’t been the same since.
Bloomberg · 09/23 10:01
Billions Rotate Through Giant Tech ETF Thanks to Options Boom
Bloomberg · 09/22 15:36
ECB’s Panetta Lays Out Case For Preemptive Monetary Stimulus
The case for the European Central Bank to add monetary stimulus gained momentum on Tuesday, with Executive Board Member Fabio Panetta saying policy makers should err on the side of doing more to keep the rebound on track.
Bloomberg · 09/22 13:41
Credit Nerves on Show as Junk Fund Sees Biggest Exodus in Months
More than two weeks of doubt and volatility in the stock market are finally starting to show up in corporate bonds.
Bloomberg · 09/22 12:36
China ETFs Give Retail Investors Access to Soaring Tech, Ant
Bloomberg · 09/22 07:45
Morgan Stanley Warns Nasdaq 100 May Fall More Than 20% From Peak
The tech-led selloff in U.S. equities is likely only halfway done, according to the Morgan Stanley strategist whose warning last month about the top-heavy market now appears prescient.
Bloomberg · 09/21 18:40
More
No Data
Learn about the latest financial forecast of BBH. Analyze the recent business situations of VanEck Vectors Biotech ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
-7.8553%
--
3-Month
-2.1376%
--
6-Month
15.0480%
--
1-Year
11.5522%
--
3-Year
5.0747%
--
5-Year
4.8871%
--
Since Inception
18.9020%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
VanEck Vectors Biotech ETF
Risk
Low risk
Inception Date
2011-12-20
Benchmark
Dow Jones US Healthcare TR
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Liao/Jin